Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 34.51

+1.4%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas who wrote (443)	8/15/1999 3:12:00 PM
From: Douglas	Read Replies (1) of 455

From 2nd Quarter Announcement: ``We are making substantial progress in implementing Procept's clinical development strategy,' said John F. Dee, President and Chief Executive Officer of Procept, Inc. ``The initiation of additional clinical trials for PRO 2000 Gel and O6-Benzylguanine is imminent. With the current government support and funding, the Company should continue to advance its clinical development and improve the potential for securing corporate partnerships.'

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next